BCAX

AS OF

Jan 14, 04:59 PM (EDT)

Price

$18.00

Change

+$0.47 (+2.68%)

Capitalization

960.33M

71 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

BCAX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Bicara Therapeutics (BCAX) Ownership - Who owns Bicara Therapeutics?

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

BCAX

Capitalization

960M

P/E Ratio

3.26

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

290M

Total Cash/Share

5.30

Total Debt

1.98M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

403M

P/B Ratio

2.38

Cash Flow

N/A

Earnings

5.38

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

14.14

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-141.04M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-25.61

Shares Held By Institutions

929M

Shares Outstanding - Current

54.8M

Total Liabilities

21.9M

Total Volume MTD

N/A

Value

N/A

Gain YTD

4.159

View a ticker or compare two or three

Compare

BCAX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for BCAX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details